Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation

Europace

Volumn 15, Issue 12, 2013, Pages 1725-1732

  Akkaya, Mehmet ^a   Higuchi, Koji ^a   Koopmann, Matthias ^a   Burgon, Nathan ^a   Erdogan, Ercan ^a   Damal, Kavitha ^a   Kholmovski, Eugene ^a   McGann, Chris ^a   Marrouche, Nassir F ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Left ventricular hypertrophy; MRI; Structural remodelling

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; FEMALE; FIBROSIS; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT ATRIUM; HEART LEFT ATRIUM FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; IMAGE ENHANCEMENT; LEFT ATRIAL TISSUE STRUCTURAL REMODELING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; LEFT VENTRICULAR HYPERTROPHY; MRI; STRUCTURAL REMODELLING;

AGED; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; FIBROSIS; HEART ATRIA; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890461602     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut147     Document Type: Article

References (29)

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114: 119-25.
2. Ausma J, Wijffels M, Thone F,Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96:3157-63.
3. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46.
4. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008;51:1-11.
5. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 2003;107:1433-9.
6. Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori M, Kamada T. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 1995;25: 1162-9.
7. Bailey GW, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med 1968;69:13-20.
8. Sinno H, Derakhchan K, Libersan D, MerhiY, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation 2003;107:1930-6.
9. KannelWB,Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
10. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9.
11. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121-31.
12. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, FishENet al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119: 1758-67.
13. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011;22: 16-22.
14. AkoumN,McGannC, Vergara G, BadgerT, Ranjan R, MahnkopfCet al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol 2012;23:44-50.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
16. Ganau A, Devereux RB,RomanMJ, de Simone G, PickeringTG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-8.
17. MarroucheNF, Natale A,WazniOM,Cheng J, YangY, PollackHet al. Left septal atrial flutter: electrophysiology, anatomy, and results of ablation. Circulation 2004;109: 2440-7.
18. Segerson NM, Daccarett M, Badger TJ, ShabaanA, Akoum N, Fish EN et al. Magnetic resonance imaging-confirmed ablative debulking of the left atrial posterior wall and septum for treatment of persistent atrial fibrillation: rationale and initial experience. J Cardiovasc Electrophysiol 2010;21:126-32.
19. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up.Areport of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Europace 2007;9:335-79.
20. Papavassiliu T, Germans T, Fluchter S, Doesch C, Suriyakamar A, HaghiD et al. Cmr findings in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Cardiovasc Magn Reson 2009;11:34.
21. Sachdev V, Shizukuda Y, Brenneman CL, Birdsall CW,Waclawiw MA, Arai AE et al. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J 2005;149:730-6.
22. Medi C, Kalman JM, Spence SJ,TehAW, Lee G, Bader I et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 2011;22:1317-24.
23. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement mri. Circ Cardiovasc Imaging 2010;3:231-9.
24. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The a4 study. Circulation 2008; 118:2498-505.
25. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-81.
26. Rotter M, Jais P, Garrigue S, Sanders P, Hocini M, Hsu LF et al. Clinical predictors of noninducibility of sustained atrial fibrillation after pulmonary vein isolation. J Cardiovasc Electrophysiol 2005;16:1298-303.
27. Essebag V, Baldessin F, Reynolds MR, McClennen S, Shah J, Kwaku KF et al. Noninducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur Heart J 2005;26:2550-5.
28. Di Biase L, Elayi CS, Fahmy TS, Martin DO,Ching CK, BarrettCet al. Atrial fibrillation ablation strategies for paroxysmal patients: Randomized comparison between different techniques. Circ Arrhythm Electrophysiol 2009;2:113-9.
29. Elayi CS, Verma A, Di Biase L, Ching CK, Patel D, Barrett C et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm 2008;5:1658-64.